These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7034762)
21. Long-term experience of spironolactone in essential hypertension. Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684 [No Abstract] [Full Text] [Related]
22. [Combination therapy with spironolactone and polythiazide in hypertension]. Lund-Johansen P Nord Med; 1971; 86(49):1471-4. PubMed ID: 5137025 [No Abstract] [Full Text] [Related]
23. Spironolactone, a reassessment. Med Lett Drugs Ther; 1975 Oct; 17(21):86-7. PubMed ID: 1186603 [No Abstract] [Full Text] [Related]
24. [Clinical experience with a new spironolactone-thiabuzide combination]. Krecke HJ; Timmler R; Betzien G Med Klin; 1968 Jun; 63(23):913-9. PubMed ID: 5666538 [No Abstract] [Full Text] [Related]
25. Hypertension in the elderly: review of therapy with a hydroflumethiazide-reserpine combination. Elkowitz EB J Am Geriatr Soc; 1979 Nov; 27(11):507-10. PubMed ID: 489858 [TBL] [Abstract][Full Text] [Related]
26. [A case of acute erythremia occurring during treatment of diabetes and hypertension]. Tanaka N; Takenouchi A Rinsho Ketsueki; 1972 Dec; 13(6):981-6. PubMed ID: 4675067 [No Abstract] [Full Text] [Related]
28. [Spironolactone in essential hypertension. Controlled study on the dose-response relationship]. Orabona ML; Maiorano G; Loiacono N Minerva Cardioangiol; 1975 Dec; 23(12):866-70. PubMed ID: 1232582 [No Abstract] [Full Text] [Related]
29. Spironolactone responsive familial hypertension. A potentially high prevalence of mineralocorticoid disease in Oman. Woodhouse NJ; Elshafie OT; Mehar A; Johnston WJ; Al-Kaabi JM Saudi Med J; 2003 Feb; 24(2):229-31. PubMed ID: 12682699 [No Abstract] [Full Text] [Related]
30. [Therapeutic experiences with Praemenstron in the premenstrual syndrome]. Beltermann R Z Allgemeinmed; 1974 Mar; 50(7):306-1. PubMed ID: 4859173 [No Abstract] [Full Text] [Related]
32. Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension. Sharabi Y; Adler E; Shamis A; Nussinovitch N; Markovitz A; Grossman E Am J Hypertens; 2006 Jul; 19(7):750-5. PubMed ID: 16814132 [TBL] [Abstract][Full Text] [Related]
33. [Hypotensive effect of spironolactone in patients with essential hypertension and aldosterone regulation disorders]. Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W Med Welt; 1980 Aug; 31(31-32):1135-7. PubMed ID: 7421547 [No Abstract] [Full Text] [Related]
34. Spironolactone use in patients with heart failure. Trujillo JM; Gonyeau MJ; DiVall MV; Alexander SL J Clin Pharm Ther; 2004 Apr; 29(2):165-70. PubMed ID: 15068406 [TBL] [Abstract][Full Text] [Related]
35. [Use of spironolactone and indapamide in the treatment of low-renin arterial hypertension]. Naudzhunas A; Bagdonas G; Yankauskene L; Kazanavichus G Ter Arkh; 2006; 78(2):61-4. PubMed ID: 16613101 [TBL] [Abstract][Full Text] [Related]
36. Severe hypertension and haemospermia--a case report. Awotedu AA West Afr J Med; 1989; 8(1):89-90. PubMed ID: 2486779 [TBL] [Abstract][Full Text] [Related]
37. [Aldactazide]. de Roquefeuil F; Goupil C Soins Cardiol; 1986 Jan; (35):I-II. PubMed ID: 3634504 [No Abstract] [Full Text] [Related]
38. Spironolactone in severe heart failure: enhances efficacy of diuretic + ACE inhibitor combinations. Prescrire Int; 2000 Oct; 9(49):158-9. PubMed ID: 11603418 [TBL] [Abstract][Full Text] [Related]
39. [Metrorrhagia on aldadien with butocin administration]. Danĕková H; Tison P Cas Lek Cesk; 1976 May; 115(18):561-2. PubMed ID: 1277238 [No Abstract] [Full Text] [Related]
40. [Treatment of idiopathic hypertension with guanabenz-mefruside]. Tomasi AM; Pirani R; Masoni C Minerva Cardioangiol; 1984 May; 32(5):339-44. PubMed ID: 6382059 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]